Protective Role of Cepharanthine Against Equid Herpesvirus Type 8 Through AMPK and Nrf2/HO-1 Pathway Activation

November 2024 in “ Viruses ”

Shuwen Li, Liangliang Li, Yueqi Sun, Muhammad Zahoor Khan, Yue Yu, Lian Ruan, Li Chen, Juan Zhao, Jinrun Jia, Yubao Li, Changfa Wang, Tongtong Wang

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on mdpi.com →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

research The Brief Overview, Antivirus and Anti-SARS-CoV-2 Activity, Quantitative Methods, and Pharmacokinetics of Cepharanthine: A Potential Small-Molecule Drug Against COVID-19

8 citations , July 2023 in “Frontiers in Pharmacology”

Cepharanthine shows promise as a COVID-19 treatment.

research The Common Regulatory Pathway of COVID-19 and Multiple Inflammatory Diseases and the Molecular Mechanism of Cepharanthine in the Treatment of COVID-19

15 citations , July 2022 in “Frontiers in Pharmacology”

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

research Cepharanthine Suppresses Herpes Simplex Virus Type 1 Replication Through the Downregulation of the PI3K/Akt and p38 MAPK Signaling Pathways

30 citations , December 2021 in “Frontiers in Microbiology”

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

research Cepharanthine: A Review of the Antiviral Potential of a Japanese-Approved Alopecia Drug in COVID-19

70 citations , July 2020 in “Pharmacological Reports”

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.